Advancing Knowledge of Down Syndrome Brain Development and Function With Human Stem Cells.
Growing Down syndrome brain cells in a dish may soon explain why attention and inhibition falter years later.
01Research in Context
What this study did
Bhattacharyya (2020) wrote a position paper. The paper says scientists can grow trisomy-21 brain cells in a dish. These cells come from iPSCs. iPSCs are skin cells turned into stem cells.
The dish acts like a tiny prenatal brain. Researchers can watch how Down syndrome brain cells grow. They can test drugs or gene fixes before birth.
What they found
The paper does not give new data. It maps a plan. The plan shows how to use iPSC brains to find early errors. These errors may cause later learning problems.
How this fits with other research
Lee et al. (2022) tested real babies. They found that 12-month-olds with Down syndrome who shift attention poorly have worse executive function at 18 months. Anita’s dish model could test why those attention circuits start off weak.
Brunamonti et al. (2011) showed teens with Down syndrome have poor inhibitory control. The iPSC model could trace that brake-system flaw back to early neuron wiring.
Chuang et al. (2015) used mouse and computer models to map autism gene cascades. Both papers push stem-cell or genetic models instead of human tissue. The methods match, but the diagnoses differ.
Why it matters
You can’t open a living fetal brain. This dish gives a safe window. If we learn which genes misfire first, we can design earlier ABA targets. Watch for future drug trials that start before birth. For now, keep screening attention and inhibition skills early. The dish data may soon tell us why those skills lag.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a quick attention-shift probe to your 12-month Down syndrome intake.
02At a glance
03Original abstract
Our bodies are made up of over 250 specific cell types, and all initially arise from stem cells during embryonic development. Stem cells have two characteristics that make them unique: (1) they are pluripotent, meaning that they can differentiate into all cell types of the body, and (2) they are capable of self-renewal to generate more of themselves and are thus able to populate an organism. Human pluripotent stem cells were first isolated from human embryos twenty years ago ( Thomson et al., 1998 ) and more recently, technology to reprogram somatic cells, such as skin and blood, to induced pluripotent stem cells has emerged ( Park et al., 2008 ; Takahashi et al., 2007 ; Yu et al., 2007 ). Induced pluripotent stem cells, or iPSCs, are particularly valuable as disease specific iPSCs can be generated from individuals with specific genetic mutations diseases. Researchers have harnessed the power of stem cells to understand many aspects of developmental biology in model organisms (e.g. worms, mice) and more recently, in humans. Human stem cells in culture recapitulate development. For example, formation of the brain occurs prenatally and follows a specific pattern of timing and cell generation. Human stem cells in the culture dish follow a similar pattern when exposed to developmental cues and can thus be used to understand aspects of prenatal human brain development that are not accessible by other means. Disease-specific iPSCs are a valuable tool to model neural development in specific neurodevelopmental disorders like Down syndrome. Down syndrome is a classic developmental disorder; mistakes that are made during development of a particular organ system result in the characteristics of the disorder. In the brain, mistakes during prenatal brain development lead to intellectual disability. Trisomy 21 (Ts21) iPSCs generated from somatic cells of Down syndrome individuals may enable us to understand the mistakes made during Down syndrome brain development.
American journal on intellectual and developmental disabilities, 2020 · doi:10.1038/nbt1201-1129